National Bank Alzheimer

NCT03687112 | Completed

• 1 other identifier: 18-DSP-03
• Study Type: observational
• Target: 167,191
• Locations: 1 country
• Sites: 1

Brief Summary

The Alzheimer's disease (MY) is a major problem of public health. The French National Database Alzheimer ( BNA) registers(records) all the medical acts made by units of memory(report) and of independent specialists in France. In 2008, the national Plan Alzheimer 2008 - 2012 had for objective to strengthen the search(research) on the Alzheimer's disease (MY) and for related disorders(confusions), to promote an early diagnosis and to improve at the same time the management of the patients and to support careers(quarries). A specific part(party) of this plan gave rise to the creation of the French national database Alzheimer ( BNA) to supply epidemiological data as well as indicators of activity. Since 2009 The information collected(taken in) in the BNA consists of a set(group) limited by data (CIMA of information minimum Corpus Alzheimer) concerning the demographic, clinical and diagnostic data defined by national consensus. The number of variables is limited to facilitate and to improve the participation in this national database. The participants are the Centers Report (CM)((LECTURE)) and Center Memory(Report) of Resources and Search(Research) (CMRR) and independent specialists. In 2015 more than 500 Centers send CIMA to the BNA. The plan Disease Neurodegenerative 2014 - 2019 wishes to pursue and to amplify the BNA.

Conditions

Alzheimer Disease

Outcome Measures

Primary Outcomes (2)

• Evolution of the morbi-mortality

  number of people suffering from a disease

  16 years

• Evolution of the morbi-mortality

  number of deaths

  16 years

Secondary Outcomes (1)

• number of the miscellaneous determiners of Access to healthcare or diagnosis

  16 years

Other Outcomes (1)

• New therapeutic plans

  16 years

Study Arms (1)

Alzheimer desease and related disorders

Alzheimer desease and related disorders

Other: non ontervention / observational study

Interventions

non ontervention / observational study OTHER

non intervention

Alzheimer desease and related disorders

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Alzheimer desease and related disorders patients

You may qualify if:

• patients consulting in French Memory Centres

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nice: lead

Study Sites (1)

Nice University Hospital

Nice, 06000, France

Location

Related Publications (1)

• Mouton A, Plonka A, Fabre R, Tran TM, Robert P, Macoir J, Manera V, Gros A. The course of primary progressive aphasia diagnosis: a cross-sectional study. Alzheimers Res Ther. 2022 May 10;14(1):64. doi: 10.1186/s13195-022-01007-6.

  PMID: 35538502 DERIVED

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Observation

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 20, 2018
• First Posted: September 27, 2018
• Study Start: January 1, 2010
• Primary Completion: December 31, 2016
• Study Completion: December 31, 2016
• Last Updated: July 22, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)